Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Use Of Rare Beauty Makeup Products

Related Conditions

Often studied with 13 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Not Yet Recruiting2
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT07899489Not Yet RecruitingPrimary

CLINICAL AND BIOLOGICAL DATABASE OF PATIENTS WITH NON-VASCULAR EHLERS-DANLOS SYNDROMES

NCT07899554Not ApplicableNot Yet RecruitingPrimary

Evaluation of the Role of Serum Tenascin-X Levels in the Diagnosis of Hypermobile Ehlers-Danlos Syndrome

NCT05945784Completed

Exploring Accessible Beauty for Individuals With Upper Extremity Deficits

Showing all 3 trials

Research Network

Common Treatments

  • Use Of Rare Beauty Makeup Products1
  • Blood Sampling1

Active Sponsors

  • Assistance Publique - Hôpitaux de Paris2
  • Casa Colina Hospital and Centers for Healthcare1

Top Investigators

Related Conditions

  • Amyotrophic Lateral Sclerosis1
  • Muscular Dystrophies1
  • Lupus Erythematosus1
  • Myasthenia Gravis1
  • Guillainbarre Syndrome1

Activity Timeline